The Mena Biologics and Biosimilars Market is estimated to be valued at US$ 502.2 Mn in 2023 and is expected to exhibit a CAGR of 4.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Mena biologics and biosimilars market consists of biologic drug products primarily used for the treatment of chronic diseases like...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian